The market for cold flu supplements market had a valuation of USD 11.93 billion in 2022, and it is projected to reach USD 21.03 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.5% during the forecast period. Key drivers of market growth include the growing occurrence of cold and flu among individuals and the increasing consumer preference for natural and herbal supplements....